Webinar on Clinical Trials During the Corona Virus Pandemic: Pragmatic Approach to the Risks

Our risk management plans for clinical trials foresee electricity breakdowns, flooding, fire, etc. but do they foresee a pandemic?

Description

Event Webinar
Type Virtual Event
Language English
Date(s) 06 Apr. 2020
Day(s) 17:00 - 18:30
Duration 1 hour 30

Our risk management plans for clinical trials foresee electricity breakdowns, flooding, fire, etc. but do they foresee a pandemic? If not then quick risk assessment adaptations and pragmatic solution finding are essential to protect your patients and the clinical trial objectives. National and international competent authorities release guidance on how to handle clinical trials in the current crisis situation but the proposals are very heterogenous. How to find the best solutions for YOUR patients in YOUR clinical trial?

Hear the recommendations from our EFGCP quality and ethics experts, discuss with us and ask your questions.

Programme

17:00 Introduction to the Webinar & Moderation, Needs to Manage a Disaste Mark Poulton, Poulton Quality Solutions
Risks to the study concerning the quality oversight in the trial from site and sponsor perspective
Cathy Dove, Dove Quality Solutions
Site risks
Claire Khalil, Evelo Biosciences
Ethical perspective
Heather Sampson, University of Toronto
Global sponsor perspective and present pragmatic options (with caveats) for sponsors
Seifeddine Amara Madi, GSK
18:30 End of the Webinar